Teva Asks Supreme Court To Block Generic MS Drugs
Teva Pharmaceuticals USA Inc. on Friday urged the U.S. Supreme Court to block the potential entry into the market of generic versions of its lucrative multiple sclerosis drug Copaxone while the...To view the full article, register now.
Already a subscriber? Click here to view full article